Pulmonx Corporation (NASDAQ: LUNG) reported Q1 EPS of ($0.36), $0.03 better than the analyst estimate of ($0.39). Revenue for the quarter came in at $22.5 million versus the consensus estimate of $22.03 million.

For earnings history and earnings-related data on Pulmonx Corporation (LUNG) click here.